Stay updated with breaking news from Quebec Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VahatiCor, Inc., a med tech company dedicated to helping patients with persistent ischemic heart disease, has announced the treatment of the first patient with the A-FLUX Reducer System, a treatment for patients with angina or chest pain.
The province's hospitals are faced with a shortage of oxygenators, key medical tools needed to perform heart surgeries.
Many DRTs either don’t resolve with treatment or recur later, raising questions around optimal management approaches.
VALBIOTIS SA Valbiotis announces the success of the TOTUM•63 mode of action clinical study, against prediabetes and the e...
No racial or ethnic disparities in long-term adverse effects or cardiovascular mortality were seen among women with obstructive coronary artery disease treated in university or academic centers.